AAminove
Back to library

GHRP-2

Human observationalWADA prohibited

Also known as: Pralmorelin

Growth-hormone secretagoguesGH secretagogueHistorically a diagnostic agent

Community-reported ranges are anecdotal and not clinically validated. Evidence grade shown reflects the strength of available human data. Not a prescription. Legal status varies by country and changes over time; verify locally.

Overview

A growth-hormone-releasing peptide used in some countries as a diagnostic agent (pralmorelin). Physique-use claims are weakly supported.

Mechanism

Ghrelin-receptor agonist stimulating GH release, with less appetite effect than GHRP-6.

Evidence

Human observationalWhat does this mean?

Some diagnostic human use; physique claims weakly supported.

Community-reported information

Community reports vary. Anecdotal and unvalidated; general information only.

General information only, not tailored to you and not a recommendation. Some regions withhold this entirely.

Half-life

Short.

Storage

Refrigerate lyophilised and reconstituted.

Commonly reported side effects

  • Water retention
  • Raised cortisol/prolactin

Legal status by region

  • USNot FDA-approved for general human use.

Legal status changes over time; verify locally before relying on this.

Citations